Durable complete remission of primary plasma cell leukemia with the bortezomib plus melphalan and prednisone (VMP) regimen.
Libby
Edward
E
Candelaria-Quintana
Dulcinea
D
Moualla
Hayan
H
Abdul-Jaleel
Maryam
M
Rabinowitz
Ian
I
D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D001897:Boronic Acids / Q000008:administration & dosage; D000069286:Bortezomib; D005260:Female; D006801:Humans; D007952:Leukemia, Plasma Cell / Q000188:drug therapy*; D008558:Melphalan / Q000008:administration & dosage; D011239:Prednisolone / Q000008:administration & dosage; D011719:Pyrazines / Q000008:administration & dosage; D012074:Remission Induction
D001897:Boronic Acids; D011719:Pyrazines; D000069286:Bortezomib; D011239:Prednisolone; D008558:Melphalan